Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7741664rdf:typepubmed:Citationlld:pubmed
pubmed-article:7741664lifeskim:mentionsumls-concept:C0006837lld:lifeskim
pubmed-article:7741664lifeskim:mentionsumls-concept:C0003308lld:lifeskim
pubmed-article:7741664lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:7741664lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7741664lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:7741664pubmed:issue10lld:pubmed
pubmed-article:7741664pubmed:dateCreated1995-6-8lld:pubmed
pubmed-article:7741664pubmed:abstractTextThe effect of subminimal inhibitory concentrations (MICs) of nystatin, amphotericin B, clotrimazole, miconazole and 5-fluorocytosine on the in vitro susceptibility of Candida albicans to physiological concentrations of apo-lactoferrin was investigated. Pre-exposure of C. albicans in 1:4 and 1:16 MICs of the antifungals resulted in an increased resistance to apo-lactoferrin-mediated cell death. Preincubation of Candida in tunicamycin (an agent that inhibits the synthesis of yeast cell-wall mannoproteins) and subsequent exposure to apo-lactoferrin enhanced the antifungal activity, whilst addition of ergosterol (a yeast cell-wall component) to the assay suspension had no significant effect. These results taken together indicate that apo-lactoferrin, an important component of saliva, interacts with cell-membrane constituents of C. albicans such as mannoproteins, and may modulate the effect of topical antifungal agents commonly prescribed for oral candidoses.lld:pubmed
pubmed-article:7741664pubmed:languageenglld:pubmed
pubmed-article:7741664pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:citationSubsetDlld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7741664pubmed:statusMEDLINElld:pubmed
pubmed-article:7741664pubmed:monthOctlld:pubmed
pubmed-article:7741664pubmed:issn0003-9969lld:pubmed
pubmed-article:7741664pubmed:authorpubmed-author:TenovuoJJlld:pubmed
pubmed-article:7741664pubmed:authorpubmed-author:HamadaTTlld:pubmed
pubmed-article:7741664pubmed:authorpubmed-author:SamaranayakeL...lld:pubmed
pubmed-article:7741664pubmed:authorpubmed-author:NikawaHHlld:pubmed
pubmed-article:7741664pubmed:issnTypePrintlld:pubmed
pubmed-article:7741664pubmed:volume39lld:pubmed
pubmed-article:7741664pubmed:ownerNLMlld:pubmed
pubmed-article:7741664pubmed:authorsCompleteYlld:pubmed
pubmed-article:7741664pubmed:pagination921-3lld:pubmed
pubmed-article:7741664pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:meshHeadingpubmed-meshheading:7741664-...lld:pubmed
pubmed-article:7741664pubmed:year1994lld:pubmed
pubmed-article:7741664pubmed:articleTitleThe effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.lld:pubmed
pubmed-article:7741664pubmed:affiliationOral Biology Unit, Prince Phillip Dental Hospital, University of Hong Kong.lld:pubmed
pubmed-article:7741664pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7741664lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7741664lld:pubmed